New Results
A new synuclein-transgenic mouse model for early Parkinson’s reveals molecular features of preclinical disease
View ORCID ProfileDiana M Hendrickx, Pierre Garcia, Amer Ashrafi, Alessia Sciortino, Kristopher J Schmit, Heike Kollmus, Nathalie Nicot, Tony Kaoma, Laurent Vallar, Manuel Buttini, View ORCID ProfileEnrico Glaab
doi: https://doi.org/10.1101/2020.04.04.016642
Diana M Hendrickx
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg
Pierre Garcia
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg
2Laboratoire National de Santé (LNS), Neuropathology Unit, Dudelange, Luxembourg
Amer Ashrafi
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg
Alessia Sciortino
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg
Kristopher J Schmit
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg
Heike Kollmus
3Department of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, Germany
Nathalie Nicot
4Quantitative Biology Unit, Luxembourg Institute of Health, Strassen, Luxembourg
Tony Kaoma
5Department of Oncology, Luxembourg Institute of Health, Strassen, Luxembourg
Laurent Vallar
6Genomics Research Unit, Luxembourg Institute of Health, Luxembourg, Luxembourg
Manuel Buttini
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg
Enrico Glaab
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg
Posted April 05, 2020.
A new synuclein-transgenic mouse model for early Parkinson’s reveals molecular features of preclinical disease
Diana M Hendrickx, Pierre Garcia, Amer Ashrafi, Alessia Sciortino, Kristopher J Schmit, Heike Kollmus, Nathalie Nicot, Tony Kaoma, Laurent Vallar, Manuel Buttini, Enrico Glaab
bioRxiv 2020.04.04.016642; doi: https://doi.org/10.1101/2020.04.04.016642
A new synuclein-transgenic mouse model for early Parkinson’s reveals molecular features of preclinical disease
Diana M Hendrickx, Pierre Garcia, Amer Ashrafi, Alessia Sciortino, Kristopher J Schmit, Heike Kollmus, Nathalie Nicot, Tony Kaoma, Laurent Vallar, Manuel Buttini, Enrico Glaab
bioRxiv 2020.04.04.016642; doi: https://doi.org/10.1101/2020.04.04.016642
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)